OROS Methylphenidate in Adolescents with ADHD
The efficacy and tolerability of osmotic-release oral system (OROS) methylphenidate in adolescents with attention deficit hyperactivity disorder (ADHD) were evaluated in a multisite controlled study at the Massachusetts General Hospital, Boston, and other centers in the United States.
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Kirja |
| Julkaistu: |
Pediatric Neurology Briefs Publishers,
2006-01-01T00:00:00Z.
|
| Aiheet: | |
| Linkit: | Connect to this object online. |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
Internet
Connect to this object online.3rd Floor Main Library
| Hyllypaikka: |
A1234.567 |
|---|---|
| Nide 1 | Saatavissa |